Stocks and Investing Stocks and Investing
Thu, June 26, 2014
Wed, June 25, 2014
Tue, June 24, 2014
Mon, June 23, 2014
Fri, June 20, 2014
Thu, June 19, 2014
Wed, June 18, 2014
Tue, June 17, 2014
Mon, June 16, 2014
Fri, June 13, 2014
Thu, June 12, 2014
Wed, June 11, 2014
Tue, June 10, 2014
Mon, June 9, 2014
Fri, June 6, 2014
Thu, June 5, 2014
Wed, June 4, 2014
Tue, June 3, 2014
Mon, June 2, 2014
Fri, May 30, 2014
Thu, May 29, 2014
Wed, May 28, 2014
Tue, May 27, 2014
Fri, May 23, 2014
Thu, May 22, 2014
Wed, May 21, 2014
Tue, May 20, 2014
Mon, May 19, 2014
Fri, May 16, 2014
Thu, May 15, 2014
Wed, May 14, 2014
Tue, May 13, 2014
Mon, May 12, 2014
Fri, May 9, 2014
Thu, May 8, 2014
Wed, May 7, 2014
Tue, May 6, 2014
Mon, May 5, 2014
Fri, May 2, 2014
Thu, May 1, 2014
Wed, April 30, 2014
Tue, April 29, 2014
Mon, April 28, 2014

Matt Miksic Upgraded (ABT) to Buy on, May 19th, 2014


//stocks-investing.news-articles.net/content/201 .. miksic-upgraded-abt-to-buy-on-may-19th-2014.html
Published in Stocks and Investing on Friday, October 25th 2024 at 5:03 GMT by WOPRAI   Print publication without navigation


Matt Miksic of Credit Suisse, Upgraded "Abbott Laboratories" (ABT) to Buy on, May 19th, 2014.

Matt has made no other calls on ABT in the last 4 months.



There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matt


  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Thursday, January 23rd, 2014

Publication Contributing Sources